Worldwide Sexual Health Market, Product Type (Gender Dysphoria Drugs, Hypoactive Sexual Desire Disorder Drugs, Premature Ejaculation Drugs, Erectile Dysfunction Drugs, and Others), by Gender (Male and Female), by Distribution Channel (Retail Pharmacies, Online Pharmacies and Hospital Pharmacies), and by Region (, Latin America, North America, Europe, Middle East, Africa and Asia Pacific) is assessed to be estimated at US$ 10,289.5 million out of 2019, and is expected to show a CAGR of 4.2%, during the forecast period (2019-2027), as featured in another report distributed by Coherent Market Insights.
Get Sample Report with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/3364
Key players in the drug business are focusing on presenting different medications for treating sexual dysfunction, which is expected to drive development of the sexual health market. For example, in 2017, Teva Pharmaceutical Industries Ltd. declared the dispatch of conventional form of Viagra (sildenafil citrate) tablets in the U.S. demonstrated for the treatment of erectile dysfunction. In addition, in September 2019, Lupin Limited reported the dispatch of Sildenafil tablets, a conventional form of Pfizer Inc’s. Viagra tablets in the U.S. shown for the treatment of erectile dysfunction.
The sexual health market is expected to observe vigorous development attributable to expanding activities by key players in the market. These players are occupied with reception of inorganic development systems, for example, joint efforts and organizations to appropriate their products around the world, and to build its customer base. For example, in May 2014, Sanofi entered an obtaining concurrence with Eli Lilly and Company to secure the rights from the Eli Lilly and Company to apply for administrative endorsement for the nonprescription Cialis (OTC) in the U Europe, U.S., Australia and Canada.
In addition, expanding approvals of medications for improving sexual health is expected to drive the worldwide sexual health market development during forecast period. For example, in March 2019, VIVUS, Inc., a biopharmaceutical organization, received approval from the Ministry of Health of the Russian Federation for its Avanafil tablet (with strength of 50 mg, 100 mg and 200 mg tablets) for treatment of erectile brokenness (ED). The product is additionally affirmed in, Saudi Arabia, Jordan, the United Arab Emirates and the Turkish markets.
Want to “ahead” with your competiors request a PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/3364
Due to an increase in drug launches for the treatment of sexual dysfunction, the global sexual health market is projected to develop at a CAGR of 4.2 percent over the forecast period (2019-2027). For example, Novitium Pharma LLC received FDA approval in June 2019 for its Sildenafil for Oral Suspension, 10mg/mL (a generic version of Pfizer’s Revatio).
Expanding clinical trials by key members for creating novel treatment alternative for treating sexual dysfunctions is required to drive the worldwide sexual health market development over the forecast period. For example, in July 31, 2019, Futura Medical Developments Ltd. started stage 3 clinical trial to show the viability of different portions of MED2005 (Glyceryl Trinitrate (GTN)) for the treatment of erectile dysfunction, and to assess the drawn out adequacy and wellbeing (a year) of MED2005. The examination is assessed to finish in October 1, 2020.
Key players operating in the sexual health market include Teva Pharmaceutical Industries Ltd., Meda Pharmaceuticals, Inc., Eli Lilly & Company, Bayer AG, Vivus, Inc., Zydus Pharmaceuticals, IVFTECH APS, Merck & Co., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis International AG, Mylan Pharmaceuticals Inc., and AstraZeneca.
Reasons to Purchase this Report
• Current and future of global Sexual Health market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Gender
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Technology Advancements
- Merger and Acquisition
- Regulatory Scenario
- PORTER’S Five Forces
- PEST Analysis
- Market Dynamics
- Global Sexual Health Market, By Product Type, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Erectile Dysfunction Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Gender Dysphoria Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Hypoactive Sexual Desire Disorder Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Premature Ejaculation Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Sexual Health Market, By Gender, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Sexual Health Market, By Distribution Channel, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Sexual Health Market, By Region, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2018 and 2027 (%)
- Y-o-Y Growth Analysis, By Region, 2016 – 2027
- Regional Trends
- North America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Gender, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Gender, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Gender, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Gender, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Gender, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Gender, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Meda Pharmaceuticals, Inc.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Eli Lilly & Company
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bayer AG
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Vivus, Inc.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Zydus Pharmaceuticals
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- IVFTECH APS
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Merck & Co.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pfizer Inc.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Sun Pharmaceutical Industries Ltd
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Novartis International AG
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Mylan Pharmaceuticals Inc.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- AstraZeneca
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837